Enovis Corp. (ENOV)
26.64
-0.98
(-3.55%)
USD |
NYSE |
Dec 31, 16:00
26.60
-0.04
(-0.13%)
After-Hours: 20:00
Enovis Research and Development Expense (TTM): 112.92M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Integra LifeSciences Holdings Corp. | 76.44M |
| Merit Medical Systems, Inc. | 96.00M |
| Repligen Corp. | 51.77M |
| Twist Bioscience Corp. | 80.28M |
| Perspective Therapeutics, Inc. | 61.22M |